ASH 2016 Annual Meeting Highlights in Multiple Myeloma

Novel Therapies – Shaji K. Kumar, MD Begin

Proteasome Inhibitors – Jacob Laubach, MD Begin

Immunotherapy – Noopur Raje, MD Begin

Minimal Residual Disease and Biomarkers – Paul G. Richardson, MD Begin